[New immunosuppressive agents for treating psoriasis].

about

[New immunosuppressive agents for treating psoriasis].

Item

http://www.wikidata.org/entity/Q44360566

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

[New immunosuppressive agents for treating psoriasis].

@en

[New immunosuppressive agents for treating psoriasis].

@nl

type

Item

label

[New immunosuppressive agents for treating psoriasis].

@en

[New immunosuppressive agents for treating psoriasis].

@nl

prefLabel

[New immunosuppressive agents for treating psoriasis].

@en

[New immunosuppressive agents for treating psoriasis].

@nl

P1476

[New immunosuppressive agents for treating psoriasis].

@en

P2093

K Rappersberger

http://www.w3.org/2001/XMLSchema#string

S Ortiz-Urda

http://www.w3.org/2001/XMLSchema#string

P2860

Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.

Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.

A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling.

Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.

Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

Making the T cell receptor go the distance: a topological view of T cell activation.

Methotrexate in psoriasis: consensus conference.

P2888

s00105-003-0499-0

P304

230-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00105-003-0499-0

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12634991

http://www.w3.org/2001/XMLSchema#string